Yolanda Piña Selected Research

Leukoencephalopathies

1/2022	Leukoencephalopathy During Daratumumab-Based Therapy: A Case Series of Two Patients with Multiple Myeloma.
1/2021	Spongiform leukoencephalopathy: A unique case of biopsy confirmed leukoencephalopathy secondary to toxic, non-inflammatory exposure.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yolanda Piña Research Topics

Disease

18	Neoplasms (Cancer) 01/2021 - 06/2007
15	Retinoblastoma (Glioblastoma, Retinal) 02/2012 - 06/2007
10	Retinal Neoplasms 02/2012 - 06/2007
4	Brain Neoplasms (Brain Tumor) 04/2022 - 03/2020
3	Melanoma (Melanoma, Malignant) 03/2023 - 01/2021
3	Neoplasm Metastasis (Metastasis) 01/2022 - 03/2009
3	Hypoxia (Hypoxemia) 02/2012 - 12/2009
2	Leukoencephalopathies 01/2022 - 01/2021
2	Glioma (Gliomas) 01/2021 - 03/2020
1	Central Nervous System Diseases (CNS Diseases) 01/2022
1	Progressive Multifocal Leukoencephalopathy 01/2022
1	Multiple Myeloma 01/2022
1	Circulating Neoplastic Cells 01/2022
1	Glioblastoma (Glioblastoma Multiforme) 01/2021
1	Astrocytoma (Pilocytic Astrocytoma) 03/2020
1	Sclerosis 09/2010
1	Endophthalmitis (Ophthalmia) 05/2010
1	Necrosis 12/2007
1	Vascular Tissue Neoplasms 06/2007

Drug/Important Bio-Agent (IBA)

12	beta Subunit Luteinizing HormoneIBA 02/2012 - 06/2007
6	Carboplatin (JM8)FDA LinkGeneric 12/2010 - 12/2007
4	Deoxyglucose (2 Deoxy D glucose)IBA 01/2012 - 07/2008
3	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 03/2023 - 03/2020
3	Immune Checkpoint InhibitorsIBA 03/2023 - 01/2021
3	anecortave acetateIBA 01/2011 - 12/2009
3	pimonidazoleIBA 12/2010 - 07/2008
2	dabrafenibIBA 01/2021 - 03/2020
2	trametinibIBA 01/2021 - 03/2020
2	Hematoxylin (Haematoxylon)IBA 02/2012 - 01/2009
2	Eosine Yellowish-(YS) (Eosin)IBA 02/2012 - 01/2009
2	Angiogenesis InhibitorsIBA 06/2010 - 12/2009
1	Monoclonal AntibodiesIBA 01/2022
1	daratumumabIBA 01/2022
1	Cell-Free Nucleic AcidsIBA 01/2022
1	Opioid Analgesics (Opioids)IBA 01/2021
1	Mitogen-Activated Protein KinasesIBA 01/2021
1	NivolumabIBA 01/2021
1	Anabolic Androgenic SteroidsIBA 01/2021
1	BenzodiazepinesIBA 01/2021
1	InsecticidesIBA 01/2021
1	IpilimumabIBA 01/2021
1	matrigelIBA 10/2010
1	Melphalan (Alkeran)FDA LinkGeneric 09/2010
1	GelatinasesIBA 06/2010
1	Matrix Metalloproteinases (MMPs)IBA 06/2010
1	Bevacizumab (Avastin)FDA Link 05/2010
1	Green Fluorescent ProteinsIBA 05/2010
1	Periodic AcidIBA 01/2009
1	Protein Isoforms (Isoforms)IBA 12/2008
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 12/2008
1	Caspase 3 (Caspase-3)IBA 12/2007

Therapy/Procedure

10	Therapeutics 03/2023 - 06/2007
10	Drug Therapy (Chemotherapy) 01/2022 - 12/2007
6	Injections 01/2012 - 12/2009
3	Aftercare (After-Treatment) 12/2010 - 12/2007
1	Radiotherapy 03/2023
1	Immunotherapy 03/2023
1	Precision Medicine 03/2020
1	Complementary Therapies (Alternative Medicine) 01/2011
1	Laser Therapy (Surgery, Laser) 09/2010
1	Lasers (Laser) 09/2010
1	Intravitreal Injections 05/2010
1	Intraocular Injections 12/2009
1	Intraperitoneal Injections 12/2009